TW201612520A - Tumor examination composition and test paper for tumor examination - Google Patents
Tumor examination composition and test paper for tumor examinationInfo
- Publication number
- TW201612520A TW201612520A TW104132865A TW104132865A TW201612520A TW 201612520 A TW201612520 A TW 201612520A TW 104132865 A TW104132865 A TW 104132865A TW 104132865 A TW104132865 A TW 104132865A TW 201612520 A TW201612520 A TW 201612520A
- Authority
- TW
- Taiwan
- Prior art keywords
- tumor examination
- examination
- composition
- tumor
- test paper
- Prior art date
Links
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
Abstract
An objective of this invention is to provide a novel malignant tumor examination method, which is unlike a blood test that usually causes harm to the human body, the method is an presureless and easy and convenient for the person under examination, and has a relatively low false positive possibility. In this invention relates to a composition for tumor examination that contains aromatic aldehydes, or cinnamic aldehydes in particular, and a test paper for tumor examination obtained by drying a filter paper added with the composition for tumor examination.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2014223288A JP5796863B1 (en) | 2014-10-31 | 2014-10-31 | Tumor examination composition and tumor examination test paper |
Publications (2)
Publication Number | Publication Date |
---|---|
TW201612520A true TW201612520A (en) | 2016-04-01 |
TWI551862B TWI551862B (en) | 2016-10-01 |
Family
ID=54348584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW104132865A TWI551862B (en) | 2014-10-31 | 2015-10-06 | Tumor examination composition and test paper for tumor examination |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5796863B1 (en) |
CN (1) | CN105572109B (en) |
HK (1) | HK1224014A1 (en) |
TW (1) | TWI551862B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109507408B (en) * | 2018-11-01 | 2019-10-11 | 陶海南 | A kind of tumor screening composition and its test paper |
CN111413393A (en) * | 2019-12-20 | 2020-07-14 | 杭州师范大学 | Method for rapidly detecting formaldehyde content in food by high-throughput reaction paper spray mass spectrometry |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010053833A1 (en) * | 2008-11-04 | 2010-05-14 | Vymedic, Llc | Antiviral supplement formulations |
EP2438445B1 (en) * | 2009-06-04 | 2014-07-16 | Metanomics Health GmbH | Methods for diagnosing prostate carcinomas |
EP2301368A1 (en) * | 2009-09-08 | 2011-03-30 | Mars, Incorporated | Composition for prevention against spoilage by microorganisms and uses and products related thereto |
KR101370613B1 (en) * | 2012-01-31 | 2014-03-26 | 주식회사 디에프아이 | Means for detecting reactive oxygen species in human |
-
2014
- 2014-10-31 JP JP2014223288A patent/JP5796863B1/en not_active Expired - Fee Related
-
2015
- 2015-10-06 TW TW104132865A patent/TWI551862B/en not_active IP Right Cessation
- 2015-10-20 CN CN201510685078.6A patent/CN105572109B/en not_active Expired - Fee Related
-
2016
- 2016-10-25 HK HK16112274.4A patent/HK1224014A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2016090335A (en) | 2016-05-23 |
JP5796863B1 (en) | 2015-10-21 |
CN105572109A (en) | 2016-05-11 |
CN105572109B (en) | 2017-09-22 |
HK1224014A1 (en) | 2017-08-11 |
TWI551862B (en) | 2016-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20200192A1 (en) | Anti-tigit antibodies | |
NZ731467A (en) | Anti-tim3 antibodies and methods of use | |
MY173162A (en) | Immune balance regulator | |
EP4060048A3 (en) | Non-invasive diagnostic method for diagnosing bladder cancer | |
MX2016002423A (en) | Diagnostic methods and compositions for treatment of glioblastoma. | |
EA201692100A8 (en) | NEW ANTIBODIES AGAINST RNF43 AND METHODS OF THEIR APPLICATION | |
EP4321866A3 (en) | Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers | |
MX2015007185A (en) | Use of eribulin in the treatment of breast cancer. | |
EA201691952A1 (en) | COMPOSITIONS AND METHODS RELEVANT TO DIAGNOSTIC PROSTATE CANCER | |
MX2020002216A (en) | Methods and compositions for detecting and treating endometriosis. | |
WO2014205266A3 (en) | Compositions and methods for detecting and treating glioblastoma | |
PH12019500725A1 (en) | Methods of treating acute kidney injury | |
WO2014200969A3 (en) | Methods of treatment of cancer | |
MA40636A (en) | Methods of detecting prostate cancer | |
TW201612520A (en) | Tumor examination composition and test paper for tumor examination | |
EP3549582A3 (en) | Novel capsazepine analogs for the treatment of cancer and other proliferative diseases | |
EA201892562A1 (en) | METHODS AND MATERIALS FOR DETERMINING STAGES AND TREATING SKIN CANCER | |
EA201790609A1 (en) | MACRO CYCLIC INHIBITORS RIP2-KINASE | |
WO2015013233A3 (en) | Methods and compositions for the treatment and diagnosis of bladder cancer | |
WO2016046759A3 (en) | Compositions and methods for treating friedreich's ataxia | |
MX2016010948A (en) | Compositions and methods for identifying b cell malignancies responsive to b cell depleting therapy. | |
MX2018003313A (en) | Modified natural killer cells having anti-fugetactic properties and uses thereof. | |
WO2017011559A8 (en) | Compositions and methods for treating cancer | |
EP4328245A3 (en) | Antibodies for use in treating conditions related to specific pcsk9 variants in specific patients populations | |
MX2018003317A (en) | Modified t-cells having anti-fugetactic properties and uses thereof. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |